Founded in 2007, Mello Biotechnology Inc. is a technologically leading company in research and commercialization of its core technologies in RNA Interference and microRNA reprogrammed pluripotent stem (mirPS^®) cells. Bridging the gap between fundamental science and solving real life problems, Mello Biotech is dedicated to rigorous laboratory research, engineering and application of cutting-edge biotechnology to better our everyday life.

Based on its patented technologies, Mello offers range of products and services including mirPS^® mir-302 expression kits, microRNA expression kits, miRNA ingredient for skin care, microRNA design, and microRNA consultation.

Headquartered in southern California, Mello Biotech has research facilities in the US and Taiwan, and Mello Biotech has representatives or collaborators in Paris, Tokyo, New York, Shanghai, Seoul, and Taipei.

Mello Biotech is a privately funded California corporation. The company is currently adequately capitalized. For future investment opportunity, please contact ir@mellobiotech.com for further information.